FDA Approved: ONUREG — Supplemental Application (Celgene Corporation)

View source ↗

Summary

FDA approved a supplemental application for ONUREG (azacitidine) to support its use in maintenance therapy for adults with acute myeloid leukemia in first compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Onureg (azacitidine)

Snippet

SUPPL AP for ONUREG (AZACITIDINE)